Brooks Gabriel 4
4 · Solid Biosciences Inc. · Filed Oct 21, 2025
Insider Transaction Report
Form 4
Brooks Gabriel
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-10-20$5.96/sh−2,895$17,254→ 33,819 total - Exercise/Conversion
Restricted Stock Units
2025-10-18−9,750→ 19,500 total→ Common Stock (9,750 underlying) - Exercise/Conversion
Common Stock
2025-10-18+9,750→ 36,714 total
Footnotes (4)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]Includes 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 30, 2025.
- [F3]This sale was made to cover withholding taxes following the vesting of previously granted RSUs pursuant to a durable automatic sale instruction letter adopted by Dr. Brooks on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Brooks.
- [F4]The RSUs were granted on October 18, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.